Enhancing Downstream Processing of Biologics or Gene Therapies
What is it about?
Sepragen’s single-use chromatography systems can purify biologics or gene therapy products while accommodating input from smaller bioreactors
Why is it important?
As productivities have improved and more niche markets and biosimilars have emerged, the age of mega-sized stainless-steel single-product plants has waned. On the rise are smaller, more targeted plants for niche markets or, increasingly, multiproduct plants.
The following have contributed to this page: Dr Naveen Kumar Singh